BLTE vs. RCMT

Last updated Jun 3, 2026

BLTE (Belite Bio Inc ADR) and RCMT (RCM Technologies, Inc.) are both stocks. BLTE operates in Biotechnology (Healthcare), while RCMT operates in Engineering & Construction (Industrials). Over the past 3 years, BLTE returned 98.89%/yr vs 10.28%/yr for RCMT. At a 0.06 correlation, their price movements are largely independent.

Performance

BLTE vs. RCMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Belite Bio Inc ADR (BLTE) and RCM Technologies, Inc. (RCMT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BLTE achieves a -15.65% return, which is significantly lower than RCMT's 12.06% return.

BLTE

• 1D: -8.21%
• 1M: -12.86%
• YTD: -15.65%
• 6M: -10.55%
• 1Y: 107.52%
• 3Y*: 98.89%
• 5Y*: —
• 10Y*: —

RCMT

• 1D: 1.82%
• 1M: -26.71%
• YTD: 12.06%
• 6M: 18.15%
• 1Y: 0.13%
• 3Y*: 10.28%
• 5Y*: 43.77%
• 10Y*: 17.27%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BLTE vs. RCMT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
BLTE Belite Bio Inc ADR	-15.65%	153.50%	37.92%	51.77%	184.66%
RCMT RCM Technologies, Inc.	12.06%	-7.74%	-23.69%	135.33%	-29.41%

Correlation

The correlation between BLTE and RCMT is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.00
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (All Time) Calculated using the full available price history since May 2, 2022	0.06

The correlation between BLTE and RCMT shifts across timeframes, from -0.00 (1 year) to 0.10 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap BLTE : $4.53B RCMT : $174.45M
EPS BLTE : -$2.34 RCMT : $2.11
PB Ratio BLTE : 5.87 RCMT : 3.94
Total Revenue (TTM) BLTE : $0.00 RCMT : $317.97M
Gross Profit (TTM) BLTE : $0.00 RCMT : $87.99M
EBITDA (TTM) BLTE : -$84.21M RCMT : $26.19M

Return for Risk

BLTE vs. RCMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLTE

BLTE Risk / Return Rank: 86
BLTE Sharpe Ratio Rank: 88
BLTE Sortino Ratio Rank: 85
BLTE Omega Ratio Rank: 82
BLTE Calmar Ratio Rank: 86
BLTE Martin Ratio Rank: 88

RCMT

RCMT Risk / Return Rank: 40
RCMT Sharpe Ratio Rank: 40
RCMT Sortino Ratio Rank: 40
RCMT Omega Ratio Rank: 40
RCMT Calmar Ratio Rank: 39
RCMT Martin Ratio Rank: 40

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLTE vs. RCMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Belite Bio Inc ADR (BLTE) and RCM Technologies, Inc. (RCMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BLTE	RCMT	Difference
Sharpe ratio Return per unit of total volatility	2.08	0.00	+2.08
Sortino ratio Return per unit of downside risk	2.74	0.42	+2.31
Omega ratio Gain probability vs. loss probability	1.34	1.06	+0.28
Calmar ratio Return relative to maximum drawdown	3.71	0.00	+3.71
Martin ratio Return relative to average drawdown	10.77	0.00	+10.76
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BLTE vs. RCMT - Sharpe Ratio Comparison

The current BLTE Sharpe Ratio is 2.08, which is higher than the RCMT Sharpe Ratio of 0.00. The chart below compares the historical Sharpe Ratios of BLTE and RCMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BLTE	RCMT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.08	0.00	+2.08
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.69	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.26	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.21	0.13	+1.07

Drawdowns

BLTE vs. RCMT - Drawdown Comparison

The maximum BLTE drawdown since its inception was -74.59%, smaller than the maximum RCMT drawdown of -97.05%. Use the drawdown chart below to compare losses from any high point for BLTE and RCMT.

Drawdown Indicators

	BLTE	RCMT	Difference
Max Drawdown Largest peak-to-trough decline	-74.59%	-97.05%	+22.46%
Max Drawdown (1Y) Largest decline over 1 year	-29.10%	-36.16%	+7.06%
Max Drawdown (3Y) Largest decline over 3 years	-36.60%	-53.15%	+16.55%
Max Drawdown (5Y) Largest decline over 5 years	—	-63.14%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-82.66%	—
Current Drawdown Current decline from peak	-29.10%	-28.20%	-0.90%
Average Drawdown Average peak-to-trough decline	-19.68%	-64.93%	+45.25%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.03%	20.25%	-10.22%

Volatility

BLTE vs. RCMT - Volatility Comparison

The current volatility for Belite Bio Inc ADR (BLTE) is 13.76%, while RCM Technologies, Inc. (RCMT) has a volatility of 25.07%. This indicates that BLTE experiences smaller price fluctuations and is considered to be less risky than RCMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BLTE	RCMT	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.76%	25.07%	-11.31%
Volatility (6M) Calculated over the trailing 6-month period	33.90%	45.00%	-11.10%
Volatility (1Y) Calculated over the trailing 1-year period	51.93%	53.27%	-1.34%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	72.16%	63.85%	+8.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	72.16%	66.26%	+5.90%

Dividends

BLTE vs. RCMT - Dividend Comparison

Neither BLTE nor RCMT has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BLTE Belite Bio Inc ADR	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
RCMT RCM Technologies, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	16.00%	0.00%	18.18%

Financials

Frequently Asked Questions

Can I hold both BLTE and RCMT in my portfolio?

BLTE and RCMT have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BLTE or RCMT?

RCMT has higher volatility (25.07%) compared to BLTE (13.76%). In terms of maximum drawdown, BLTE dropped -74.59% vs RCMT's -97.05%.

Which has better risk-adjusted returns?

BLTE currently has the higher Sharpe Ratio (2.08 vs 0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.